Isolate | Clade | ESBL | Antibiotic resistance profile | Chromosomal Point Mutations | Beta-lactamases | Aminogylcosides | Quinolones resistance | Sulfonamide resistance | Trimethoprim resistance | Macrolide resistance | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
ESBL | AmpC | Carbapenem | ||||||||||
TEM, CTX-M | ACT | OXA, NDM | Qnr | Sul | dfrA | mpH | ||||||
4 | A | Positive | Amoxicillin/clavulanic acid, Ampicillin, Cefalotin, Cefixime, Cefoxitin, Ceftazidime, Ceftriaxone, Ciprofloxacin, Co-trimoxazole, Gentamicin, Piperacillin/tazobactam, Ticarcillin | gyrA: S83L, D87N parC: S57T, S80I parE: S458A | TEM (4,166) CTX-M (42, 27, 3, 55, 142, 15, 33, 88, 66) | Â | OXA-1 NDM-5 | APH(6)-Id aadA (2, 3, 2) | Â | Sul (2,1) | (dfrA1, 14, 12) | mphA |
5 | A | Positive | Amoxicillin/clavulanic acid, Ampicillin, Cefalotin, Cefixime, Cefoxitin, Ceftazidime, Ceftriaxone, Ciprofloxacin, Co-trimoxazole, Gentamicin, Nitrofurantoin, Norfloxacin, Piperacillin/tazobactam, Ticarcillin, Ertapenem | gyrA: S83L, D87N parC: S80I parE: S458A | TEM- (4, 33) | ACT-5 | NDM (5, 4, 2, 7, 1, 9) | aadA (2, 3, 17) | Â | sul 1 | dfrA12 | mphA |
7 | A | Positive | Amoxicillin/clavulanic acid, Ampicillin, Cefalotin, Cefixime, Ciprofloxacin, Co-trimoxazole, Ticarcillin, Ertapenem | gyrA: S83L, D87N parC: S80I parE: S458A | TEM- (4, 159, 166,1) | ACT- (5, 14) | OXA-1 NDM (5,4,8) | aadA2 | Â | Â | dfrA12 | Â |
11 | A | Negative | Ampicillin, Co-trimoxazole | gyrA: S83L, D87N parC: S80I parE: S458A | TEM- (4,158, 33, 148, 1, 169) CTX-M (15, 117, 103, 3, 55, 82, 52, 101, 114, 88, 66, 42, 28, 79, 71) | Â | Â | AadA (8, 23, 24) | Â | Â | dfrA1 | mphA |
16 | A | Positive | Amoxicillin/clavulanic acid, Ampicillin, Cefalotin, Cefixime, Ceftazidime, Ceftriaxone, Ciprofloxacin, Norfloxacin, Piperacillin/tazobactam, Ticarcillin | gyrA: S83L | TEM (4, 166) | ACT- (5, 14) | OXA-1 | APH ((6)-Id, (3ʺ)-Ib) |  | Sul (1, 2) | dfrA17 | mphA |
22 | A | Negative | Cefalotin | Â | Â | ACT-5 | Â | Â | Â | Â | Â | Â |
23 | A | Positive | Ampicillin, Cefalotin, Cefixime, Cefoxitin, Ceftazidime, Ceftriaxone, Ciprofloxacin, Co-trimoxazole, Gentamicin, Norfloxacin, Piperacillin, Ticarcillin | gyrA: S83L, D87N parC: S80I parE: S458A | CTX-M (15,82,139,54,114,80,22,224,33,117,71) | ACT-5 | OXA- (1, 320) | AAC(3)- (IIc, IIa) aadA5 | Â | Sul1 | dfrA17 | Â |
1 | B | Positive | Ciprofloxacin | gyrA: S83L |  | ACT- (14, 5) |  | APH(6)-Id, (3ʺ)-Ib) |  | sul2 |  |  |
2 | B | Positive | Ampicillin, Cefalotin, Cefixime, Ceftriaxone, Ciprofloxacin, Ticarcillin | gyrA: S83L, D87N parC: E84K | TEM- (4, 76, 95,1,71, 115) CTX-M (15, 55, 101, 114, 82, 33, 103, 22, 132, 3, 61) | ACT- (5, 14) | Â | Â | Qnr (S1, S3, S4) | Sul (2,1) | Â | Â |
3 | B | Positive | Amoxicillin/clavulanic acid, Ampicillin, Cefalotin, Cefixime, Cefoxitin, Ceftazidime, Ceftriaxone, Ciprofloxacin, Co-trimoxazole, Ertapenem, Gentamicin, Piperacillin/tazobactam, Ticarcillin | gyrA: S83L, D87N parC: S80I | TEM- (4,1, 206, 33, 166, 198,143) CTX-M (55, 15, 114, 33, 52, 101, 66, 79, 71, 142) | ACT-(5, 14) | OXA-1 NDM- (5, 4, 9) | AAC(3)-IIc (3)-IIa, (6')-Ib) | Â | sul1 | dfr (A17, A12) | mphA |
6 | B | Positive | Ampicillin, Ceftriaxone, Ciprofloxacin | gyrA: S83L, D87N parC: S80I, E84V parE: I529L | CTX-M (27, 129, 102, 85, 9, 19, 98, 47, 113, 48) | ACT-5 |  | APH(6)-Id, (3ʺ)-Ib aadA5 |  | Sul (1, 2) | dfrA17 | mphA |
8 | B | Positive | Ampicillin, Cefalotin, Cefixime, Cefoxitin, Ceftazidime, Ceftriaxone, Co-trimoxazole, Ticarcillin | gyrA: S83L, D87N parC: S80I parE: L416F | TEM- (4,76, 70, 166) CTX-M (15, 55, 117, 71, 103, 82, 139, 101, 69,3, 54, 114, 22, 79, 33, 88) | ACT-(5, 14) | Â | APH(6)-Id aadA5 | Â | Sul (1, 2) | dfrA17 | mphA |
9 | B | Positive | Ampicillin, Cefalotin, Cefixime, Ceftriaxone, Ciprofloxacin, Co-trimoxazole, Ticarcillin | gyrA: D87G | CTX-M (15, 82, 55, 114, 71, 3, 117, 139, 54, 33, 88, 142, 103, 123, 79) | ACT-(5, 14) | Â | Â | Â | Â | Â | Â |
10 | B | Negative | Ciprofloxacin | gyrA: S83L |  | ACT-(5,14, 7) |  | APH(3ʹ)-IIa |  |  |  |  |
14 | B | Positive | Amoxicillin/clavulanic acid, Ampicillin, Cefalotin, Cefixime, Cefoxitin, Ceftazidime, Ceftriaxone, Ciprofloxacin, Ertapenem, Norfloxacin Piperacillin/tazobactam, Ticarcillin | Â | Â | ACT-(5,14, 9) | Â | Â | QnrS1 | sul2 | dfrA12 | Â |
15 | B | Positive | Amoxicillin/clavulanic acid, Ampicillin, Cefalotin, Cefixime, Ceftazidime, Ceftriaxone, Ciprofloxacin, Gentamicin, Norfloxacin, Piperacillin, Ticarcillin | gyrA: S83L, D87N parC: S80I, E84V parE: I529L | TEM- (4,176, 105, 163) CTX-M (15,82,101,103,3,62,55,33,71,142) | ACT-(5,14) | OXA-1 NDM-5 | APH(6)-Id, (3ʺ)-Ib) AAC ((3)-IIc, (3)-Iia) |  | sul2 |  |  |
17 | B | Positive | Ampicillin, Cefalotin, Cefixime, Ceftazidime, Ceftriaxone, Ciprofloxacin, Gentamicin, Norfloxacin, Ticarcillin | gyrA: S83L, D87N parC: S80I, E84V parE: I529L | TEM- (4,176, 76, 148, 146, 137) CTX-M (15,117,55,82,22,132,28,53,71,88,72) | ACT-5 | OXA-1 | AAC(3)-IIc, (3)-IIa) | Â | Â | Â | Â |
18 | B | Positive | Amoxicillin/clavulanic acid, Ampicillin, Cefalotin, Cefixime, Ceftazidime, Ceftriaxone, Ciprofloxacin, Co-trimoxazole, Gentamicin, Norfloxacin, Piperacillin, Ticarcillin | gyrA: S83L, D87N parC: S80I, E84V parE: I529L | CTX-M (15,42,114,82,123,55,79,33,117) | ACT- (5, 14) | OXA-1 | APH(6)-Id, (3ʺ)-Ib), aadA5 |  | Sul (1, 2) | dfrA17 | mphA |
19 | B | Negative | Amoxicillin/clavulanic acid, Ampicillin, Cefalotin, Cefixime, Cefoxitin, Ceftazidime, Ceftriaxone, Ciprofloxacin, Co-trimoxazole, Ertapenem, Norfloxacin, Piperacillin, Ticarcillin | gyrA: S83L | TEM-4 | ACT- (5,14) | OXA- (1,224,31) | aadA5 | QnrB4 | sul1 | dfrA17 | mphA |